annual EBITDA:
-$376.16M-$142.66M(-61.10%)Summary
- As of today (May 29, 2025), RNA annual EBITDA is -$376.16 million, with the most recent change of -$142.66 million (-61.10%) on December 31, 2024.
- During the last 3 years, RNA annual EBITDA has fallen by -$258.75 million (-220.38%).
- RNA annual EBITDA is now -3618.83% below its all-time high of -$10.12 million, reached on December 31, 2018.
Performance
RNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$130.73M-$10.48M(-8.72%)Summary
- As of today (May 29, 2025), RNA quarterly EBITDA is -$130.73 million, with the most recent change of -$10.48 million (-8.72%) on March 31, 2025.
- Over the past year, RNA quarterly EBITDA has dropped by -$54.19 million (-70.79%).
- RNA quarterly EBITDA is now -6173.13% below its all-time high of -$2.08 million, reached on March 31, 2019.
Performance
RNA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$430.35M-$54.19M(-14.41%)Summary
- As of today (May 29, 2025), RNA TTM EBITDA is -$430.35 million, with the most recent change of -$54.19 million (-14.41%) on March 31, 2025.
- Over the past year, RNA TTM EBITDA has dropped by -$177.51 million (-70.21%).
- RNA TTM EBITDA is now -20550.05% below its all-time high of -$2.08 million, reached on March 31, 2019.
Performance
RNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.1% | -70.8% | -70.2% |
| 3 y3 years | -220.4% | -282.9% | -236.7% |
| 5 y5 years | -2112.8% | -2106.8% | -1965.1% |
RNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -220.4% | at low | -282.9% | at low | -236.7% | at low |
| 5 y | 5-year | -2112.8% | at low | -2106.8% | at low | -1965.1% | at low |
| alltime | all time | -3618.8% | at low | -6173.1% | at low | <-9999.0% | at low |
RNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$130.73M(+8.7%) | -$430.35M(+14.4%) |
| Dec 2024 | -$376.16M(+61.1%) | -$120.25M(+23.4%) | -$376.16M(+16.8%) |
| Sep 2024 | - | -$97.42M(+18.9%) | -$322.04M(+13.9%) |
| Jun 2024 | - | -$81.94M(+7.0%) | -$282.67M(+11.8%) |
| Mar 2024 | - | -$76.55M(+15.8%) | -$252.84M(+8.3%) |
| Dec 2023 | -$233.50M(+31.5%) | -$66.13M(+13.9%) | -$233.50M(+6.0%) |
| Sep 2023 | - | -$58.06M(+11.4%) | -$220.21M(+6.5%) |
| Jun 2023 | - | -$52.10M(-8.9%) | -$206.71M(+3.1%) |
| Mar 2023 | - | -$57.20M(+8.3%) | -$200.59M(+13.0%) |
| Dec 2022 | -$177.53M(+51.2%) | -$52.84M(+18.6%) | -$177.53M(+8.9%) |
| Sep 2022 | - | -$44.56M(-3.1%) | -$163.02M(+10.5%) |
| Jun 2022 | - | -$45.98M(+34.6%) | -$147.57M(+15.5%) |
| Mar 2022 | - | -$34.15M(-10.9%) | -$127.81M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$117.41M(+168.2%) | -$38.34M(+31.7%) | -$117.41M(+23.3%) |
| Sep 2021 | - | -$29.10M(+11.0%) | -$95.23M(+22.9%) |
| Jun 2021 | - | -$26.22M(+10.4%) | -$77.47M(+25.8%) |
| Mar 2021 | - | -$23.75M(+47.0%) | -$61.60M(+40.7%) |
| Dec 2020 | -$43.77M(+157.5%) | -$16.16M(+42.5%) | -$43.77M(+30.3%) |
| Sep 2020 | - | -$11.34M(+9.5%) | -$33.59M(+22.7%) |
| Jun 2020 | - | -$10.35M(+74.7%) | -$27.38M(+31.4%) |
| Mar 2020 | - | -$5.92M(-0.9%) | -$20.84M(+22.6%) |
| Dec 2019 | -$17.00M(+68.1%) | -$5.98M(+16.8%) | -$17.00M(+54.3%) |
| Sep 2019 | - | -$5.12M(+34.3%) | -$11.02M(+86.9%) |
| Jun 2019 | - | -$3.81M(+83.0%) | -$5.90M(+183.0%) |
| Mar 2019 | - | -$2.08M | -$2.08M |
| Dec 2018 | -$10.12M | - | - |
FAQ
- What is Avidity Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Avidity Biosciences?
- What is Avidity Biosciences annual EBITDA year-on-year change?
- What is Avidity Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Avidity Biosciences?
- What is Avidity Biosciences quarterly EBITDA year-on-year change?
- What is Avidity Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Avidity Biosciences?
- What is Avidity Biosciences TTM EBITDA year-on-year change?
What is Avidity Biosciences annual EBITDA?
The current annual EBITDA of RNA is -$376.16M
What is the all time high annual EBITDA for Avidity Biosciences?
Avidity Biosciences all-time high annual EBITDA is -$10.12M
What is Avidity Biosciences annual EBITDA year-on-year change?
Over the past year, RNA annual EBITDA has changed by -$142.66M (-61.10%)
What is Avidity Biosciences quarterly EBITDA?
The current quarterly EBITDA of RNA is -$130.73M
What is the all time high quarterly EBITDA for Avidity Biosciences?
Avidity Biosciences all-time high quarterly EBITDA is -$2.08M
What is Avidity Biosciences quarterly EBITDA year-on-year change?
Over the past year, RNA quarterly EBITDA has changed by -$54.19M (-70.79%)
What is Avidity Biosciences TTM EBITDA?
The current TTM EBITDA of RNA is -$430.35M
What is the all time high TTM EBITDA for Avidity Biosciences?
Avidity Biosciences all-time high TTM EBITDA is -$2.08M
What is Avidity Biosciences TTM EBITDA year-on-year change?
Over the past year, RNA TTM EBITDA has changed by -$177.51M (-70.21%)